Pitcairn’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-8,634
Closed -$390K 548
2020
Q2
$390K Buy
8,634
+762
+10% +$34.1K 0.04% 283
2020
Q1
$303K Buy
7,872
+1,493
+23% +$68.7K 0.04% 298
2019
Q4
$295K Sell
6,379
-50
-0.8% -$2.17K 0.03% 405
2019
Q3
$261K Buy
6,429
+832
+15% +$35.9K 0.03% 440
2019
Q2
$269K Buy
5,597
+168
+3% +$8.83K 0.03% 432
2019
Q1
$340K Sell
5,429
-381
-7% -$26.2K 0.04% 316
2018
Q4
$347K Sell
5,810
-1,767
-23% -$106K 0.04% 261
2018
Q3
$488K Sell
7,577
-868
-10% -$48.4K 0.05% 259
2018
Q2
$380K Sell
8,445
-1,169
-12% -$46.6K 0.04% 321
2018
Q1
$298K Buy
9,614
+2,875
+43% +$94.5K 0.03% 385
2017
Q4
$202K Sell
6,739
-336
-5% -$9.73K 0.02% 506
2017
Q3
$234K Sell
7,075
-117
-2% -$4.05K 0.03% 434
2017
Q2
$241K Sell
7,192
-252
-3% -$7.52K 0.03% 401
2017
Q1
$215K Buy
+7,444
New +$184K 0.03% 454

Other funds holding BEAT

Pitcairn's BEAT Position: Q3 2020 in Review

Pitcairn sold out of BioTelemetry, Inc. (BEAT) in Q3 2020, closing a stake of 8,634 shares — an estimated $390K sold.

Pitcairn first reported a position in BEAT in Q1 2017 and held it in 14 quarters. The position peaked at $488K in Q3 2018. 209 funds tracked by Wall St. Rank hold BEAT as of Q3 2020.

  • Pitcairn reported no remaining BioTelemetry, Inc. position as of Q3 2020 after selling out during the quarter.
  • Pitcairn sold 8,634 BioTelemetry, Inc. shares in Q3 2020, an estimated $390K.
  • Pitcairn first reported a position in BioTelemetry, Inc. in Q1 2017 and held it in 14 quarters.
  • Pitcairn's BioTelemetry, Inc. position peaked at $488K in Q3 2018.
  • 209 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2020.

Based on Pitcairn's 13F filing for Q3 2020, filed 3 Nov 2020.